![](https://investorshub.advfn.com/uicon/756666.png?cb=1598094430)
Friday, October 30, 2020 7:45:16 PM
"The Covid study is moving forward with incredible velocity. We expect to read out the Phase 3 trial by the end of the year. But, ah... 2 weeks from now, there's going to be a meeting of the data safety monitoring board (DSMB). And, they're going to review the first 102 patients in the trial. They have the potential to see both futility, which we hope they won't see. Or perhaps they will see overwhelming evidence of efficacy. Either, which would lead to stopping the trial."
Dr. Javitt
2020-10-15 Solebury Trout Webcast
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM